Daily GLP-1 receptor agonist pill leads to ‘significant’ weight loss – The Pharmaceutical Journal

1. Daily GLP-1 receptor agonist pill leads to ‘significant’ weight loss  The Pharmaceutical Journal
2. Eli Lilly cautious on using FDA fast-track voucher for weight-loss pill  Reuters
3. Lilly’s orforglipron surpasses Novo’s oral rival in head-to-head test  FirstWord Pharma
4. Jim Cramer says Eli Lilly’s obesity pill could be more of a ‘lifetime drug’ than shots  CNBC
5. Data on Eli Lilly’s Weight Loss Pill Haven’t Thrilled Investors. New Updates Are Complicating the Picture.  Barron’s

Continue Reading